A first-in-human dose-escalation study of ME-143, a second...

Investigational New Drugs 2014 / 02 Vol. 32; Iss. 1

A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors

Pant, Shubham, Burris, Howard A., Moore, Kathleen, Bendell, Johanna C., Kurkjian, Carla, Jones, Suzanne F., Moreno, Ofir, Kuhn, John G., McMeekin, Scott, Infante, Jeffrey R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-013-9949-4
Date:
February, 2014
File:
PDF, 176 KB
english, 2014
Conversion to is in progress
Conversion to is failed